tazemetostat到哪里去买（价格|靶点）

不超过200字的话，以下是关于“tazemetostat”的文章开头描述：在现代医药领域，创新药物的研发不断为患者带来新的希望。tazemetostat，作为一种新型抗肿瘤药物，引起了广泛关注。其主要通过抑制肿瘤细胞中特定酶的活性，从而有效遏制肿瘤的生长与扩散。作为一种具有潜力的精准治疗药物，tazemetostat为众多癌症患者带来了全新的治疗选择，有望改善其生活质量，延长生存期。本文将详细介绍tazemetostat的作用机制、临床应用及前景展望。

tazemetostat到哪里去买

一、认识Tazemetostat——新型抗癌药物的力量

在众多抗癌药物中，Tazemetostat作为一种新型抗癌药物，备受瞩目。它主要针对某些特定的基因突变，通过抑制肿瘤细胞的生长和扩散，为肿瘤患者带来新的治疗选择。

二、Tazemetostat的适应症和疗效

Tazemetostat主要用于治疗某些特定基因突变的恶性肿瘤，如滤泡性淋巴瘤和上皮样肉瘤。多项临床试验表明，Tazemetostat在这些病症的治疗中表现出了较好的疗效，为患者带来了希望。

三、Tazemetostat到哪里去买？——全球好药网为您提供解决方案

由于Tazemetostat是一种新型抗癌药物，并非所有药店都有销售。那么，如何购买到这款药物呢？全球好药网作为专业的抗癌新药、热门抗癌药信息交流平台，可以为患者提供详细的购药指南。

1. 访问全球好药网官方网站，搜索Tazemetostat相关信息；

2. 了解药物的适应症、用法用量、副作用等详细信息；

3. 通过平台提供的联系方式，咨询专业药师，获取购药建议；

4. 根据药师的建议，选择合适的购买渠道，如正规药店、医院或跨境电商平台。

四、患者交流微信——haoyao6040，共享抗癌经验

为了帮助更多肿瘤患者了解Tazemetostat的使用经验和抗癌心得，全球好药网特设患者交流微信：haoyao6040。添加微信后，您可以与众多肿瘤患者在线交流，分享抗癌经验，共同寻找治疗希望。

五、温馨提示

Tazemetostat作为一种新型抗癌药物，为肿瘤患者带来了新的治疗选择。全球好药网致力于为患者提供专业的抗癌药物信息，帮助每一个患者找到合适的治疗方法。如果您想了解Tazemetostat的更多信息，或者寻求购药建议，欢迎添加患者交流微信：haoyao6040，让我们共同为抗癌事业助力。

Tazemetostat: Uses, Side Effects, and mechanism of Action

What is Tazemetostat?

Tazemetostat is an oral inhibitor of EZH2, an enzyme that is a component of the polycomb repressive complex 2 (PRC2). It is used to treat certain types of cancer, including epithelioid sarcoma and myxoid/round cell liposarcoma.

Approved Uses of Tazemetostat

In the United States, tazemetostat is approved for the treatment of:

• Relapsed or refractory epithelioid sarcoma in patients aged 16 years and older.
• Advanced myxoid/round cell liposarcoma in patients who have received prior anthracycline-containing regimen.

The European Medicines Agency (EMA) has also granted conditional marketing authorization for tazemetostat for the same indications.

How Does Tazemetostat Work?

Tazemetostat's mechanism of action is unique in that it targets the EZH2 enzyme, which is involved in regulating gene expression. In certain cancers, EZH2 is overexpressed and leads to the silencing of tumor suppressor genes, promoting cancer cell growth and survival. By inhibiting EZH2, tazemetostat helps to reverse this process, leading to the re-expression of these genes and the death of cancer cells.

Side Effects of Tazemetostat

Common side effects of tazemetostat include:

• NAusea
• Vomiting
• Diarrhea
• Peripheral edema
• Fatigue

More serious side effects may include:

• Liver problems
• High blood pressure
• Low blood platelet levels (thrombocytopenia)
• Increased creatinine levels

Patients should be monitored closely by their healthcare provider for any adverse reactions.

Drug Interactions

Tazemetostat may interact with other medications, including those that increase the risk of bleeding or affect liver function. It is important for patients to inform their healthcare providers of all medications they are taking before starting tazemetostat.

Dosage and Administration

The recommended dose of tazemetostat for the treatment of epithelioid sarcoma is 800 mg orally, twice daily. For the treatment of myxoid/round cell liposarcoma, the recommended dose is 800 mg orally, once daily. Tazemetostat should be taken with food and at around the same times each day.

Warnings and Precautions

Patients with a known hypersensitivity to tazemetostat should not take this medication. Additionally, due to the potential for serious side effects, patients should be monitored for signs of liver toxicity, thrombocytopenia, and other adverse reactions. Women who are pregnant or breastfeeding should not take tazemetostat, as it may harm the fetus or infant.

Research and Future Uses

Ongoing research is exploring the use of tazemetostat in combination with other cancer therapies, as well as its potential in treating other types of cancer. Early studies suggest that it may be effective in treating certain lymphomas and solid tumors.

In conclusion, tazemetostat represents an important advancement in the treatment of specific types of cancer. Its unique mechanism of action and potential for use in combination with other therapies offer new hope for patients with these challenging diseases.